Found: 44
Select item for more details and to access through your institution.
Biomarker-driven phase Ib clinical trial of OPB-111077 in acute myeloid leukemia.
- Published in:
- Medicine International (2754-3242), 2022, v. 2, n. 2, p. 1, doi. 10.3892/mi.2022.32
- By:
- Publication type:
- Article
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 6, p. 1239, doi. 10.1111/bjh.18815
- By:
- Publication type:
- Article
A prognostic model for survival after salvage treatment with FLAG-Ida +/− gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 5, p. 700, doi. 10.1111/bjh.14107
- By:
- Publication type:
- Article
Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 2, p. 188, doi. 10.1111/bjh.13273
- By:
- Publication type:
- Article
Extranodal natural killer/T‐cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 6, p. E134, doi. 10.1002/ajh.26904
- By:
- Publication type:
- Article
Micafungin as antifungal prophylaxis in non-transplanted haemotological patients.
- Published in:
- Revista Española de Quimioterapia, 2020, v. 33, n. 1, p. 44, doi. 10.37201/req/067.2019
- By:
- Publication type:
- Article
FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients—efficacy and microbiologic safety.
- Published in:
- Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-023-07702-5
- By:
- Publication type:
- Article
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correction to: Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 1, p. 43, doi. 10.1007/s00277-013-1914-y
- By:
- Publication type:
- Article
Immunosenescence: limitations of natural killer cell-based cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 2, p. 233, doi. 10.1007/s00262-016-1882-x
- By:
- Publication type:
- Article
Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 4, p. 453, doi. 10.1007/s00262-015-1720-6
- By:
- Publication type:
- Article
Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1195, doi. 10.1007/s00262-011-1050-2
- By:
- Publication type:
- Article
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 438, doi. 10.3390/cancers15020438
- By:
- Publication type:
- Article
Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5799, doi. 10.3390/cancers14235799
- By:
- Publication type:
- Article
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3 -ITD Mutation-Positive Acute Myeloid Leukemia.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2817, doi. 10.3390/cancers14112817
- By:
- Publication type:
- Article
The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2458, doi. 10.3390/cancers13102458
- By:
- Publication type:
- Article
Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2171, doi. 10.3390/cancers12082171
- By:
- Publication type:
- Article
DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 877, doi. 10.3390/cancers11060877
- By:
- Publication type:
- Article
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 138, doi. 10.1111/ejh.13417
- By:
- Publication type:
- Article
Clinical outcomes after CPX‐351 in patients with high‐risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 14, p. 14892, doi. 10.1002/cam4.6120
- By:
- Publication type:
- Article
A pediatric regimen for adolescents and young adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 7, p. 2317, doi. 10.1002/cam4.2814
- By:
- Publication type:
- Article
Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 3, p. 162, doi. 10.1111/ejh.13346
- By:
- Publication type:
- Article
Increased survival due to lower toxicity for high‐risk T‐cell acute lymphoblastic leukemia patients in two consecutive pediatric‐inspired PETHEMA trials.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 1, p. 79, doi. 10.1111/ejh.13178
- By:
- Publication type:
- Article
Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. The GELTAMO experience.
- Published in:
- European Journal of Haematology, 2007, v. 78, n. 4, p. 290, doi. 10.1111/j.1600-0609.2007.00815.x
- By:
- Publication type:
- Article
High-Dose Chemotherapy and Immunotherapy in Adult Burkitt Lymphoma: Comparison of Results in Human Immunodeficiency Vfrus-lnfected and Noninfected Patients.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 1, p. 117, doi. 10.1002/cncr.23522
- By:
- Publication type:
- Article
Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Resolution of left and right ventricular thrombosis secondary to hypereosinophilic syndrome (lymphoproliferative variant) with reduced intensity conditioning allogenic stem cell transplantation.
- Published in:
- 2008
- By:
- Publication type:
- Letter
NPM1+ /FLT3- Acute Myeloid Leukemia after JAK2-V617F+ Essential Thrombocythemia. Management and Prognosis.
- Published in:
- Plasmatology, 2021, v. 15, p. 1, doi. 10.1177/26348535211028192
- By:
- Publication type:
- Article
Polatuzumab Vedotin plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Results from the Phase III POLARIX Study
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 56
- By:
- Publication type:
- Article
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00835-5
- By:
- Publication type:
- Article
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00835-5
- By:
- Publication type:
- Article
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.
- Published in:
- 2021
- By:
- Publication type:
- Letter
In Vitro Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia Patients.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.00931
- By:
- Publication type:
- Article
Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: Final results of a phase 2 study (Burkimab)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 9, p. 1660, doi. 10.1002/cncr.27918
- By:
- Publication type:
- Article
Diarrhoea caused by colonic relapse of follicular lymphoma.
- Published in:
- 2009
- By:
- Publication type:
- Other
Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients.
- Published in:
- Immunology & Cell Biology, 2012, v. 90, n. 1, p. 109, doi. 10.1038/icb.2011.15
- By:
- Publication type:
- Article
The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1054458
- By:
- Publication type:
- Article
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 20, p. 3436, doi. 10.1002/cncr.35431
- By:
- Publication type:
- Article
A phase 3 trial of azacitidine versus a semi‐intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 12, p. 2003, doi. 10.1002/cncr.33403
- By:
- Publication type:
- Article